Biblio

Author Title Type [ Year(Desc)]
Filters: Author is Etzion, Yoram  [Clear All Filters]
2018
Drabkin M, Zilberberg N, Menahem S, Mulla W, Halperin D, Yogev Y, Wormser O, Perez Y, Kadir R, Etzion Y, et al. Nocturnal Atrial Fibrillation Caused by Mutation in KCND2, Encoding Pore-Forming (α) Subunit of the Cardiac Kv4.2 Potassium Channel. Circ Genom Precis Med. 2018;11(11):e002293.
2021
Stenzig J, Lemoine MD, Stoter AMS, Wrona KM, Lemme M, Mulla W, Etzion Y, Eschenhagen T, Hirt MN. Recapitulation of dyssynchrony-associated contractile impairment in asymmetrically paced engineered heart tissue. J Mol Cell Cardiol. 2021.
2022
Burg S, Shapiro S, Peretz A, Haimov E, Redko B, Yeheskel A, Simhaev L, Engel H, Raveh A, Ben-Bassat A, et al. Allosteric inhibitors targeting the calmodulin-PIP2 interface of SK4 K channels for atrial fibrillation treatment. Proc Natl Acad Sci U S A. 2022;119(34):e2202926119.
Gil H, Goldshtein M, Etzion S, Elyagon S, Hadad U, Etzion Y, Cohen S. Defining the timeline of periostin upregulation in cardiac fibrosis following acute myocardial infarction in mice. Sci Rep. 2022;12(1):21863.
2023
Altieri DI, Etzion Y, Anderson HD. Cannabinoid receptor agonist attenuates angiotensin II-induced enlargement and mitochondrial dysfunction in rat atrial cardiomyocytes. Front Pharmacol. 2023;14:1142583.
Korover N, Etzion S, Cherniak A, Rabinski T, Levitas A, Etzion Y, Ofir R, Parvari R, Cohen S. Functional defects in hiPSCs-derived cardiomyocytes from patients with a PLEKHM2-mutation associated with dilated cardiomyopathy and left ventricular non-compaction. Biol Res. 2023;56(1):34.
Murninkas M, Gillis R, Elyagon S, Levi O, Mulla W, Katz A, Etzion Y, Gradwohl G. An Objective Tool for Quantifying Atrial Fibrillation Substrate in Rats. Am J Physiol Heart Circ Physiol. 2023.
Itzhar A, Yosef G, Eilon-Ashkenazy M, Shmidov Y, Gil H, Lacham-Hartman S, Elyagon S, Etzion S, Bitton R, Cohen S, et al. Potent inhibition of MMP-9 by a novel sustained-release platform attenuates left ventricular remodeling following myocardial infarction. J Control Release. 2023.